WHO expecting more info from Bharat Biotech for Covaxin approval

Covaxin is one of the three approved vaccines that have been used in India for the country's vaccination drive for adults.

The World Health Organization said on Monday it expects Bharat Biotech to provide more information on its COVID-19 vaccine in a further setback to the Indian company's hopes of getting an emergency-use listing for the shot.

Without WHO's nod the two-dose Covaxin is unlikely to be accepted as a valid COVID-19 vaccine around the world. Bharat Biotech has been pursuing a WHO emergency-use listing for several months, having submitted data on a rolling basis since July.

"We are aware that many people are waiting for WHO's recommendation for (Bharat Biotech's) Covaxin to be included in the #COVID19 Emergency Use Listing,